| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |